vidarabine has been researched along with Aggressive Natural Killer Cell Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antic, D; Gotic, M; Jakovic, L; Jankovic, S; Mihaljevic, B; Perunicic-Jovanovic, M; Sretenovic, A | 1 |
| Aldred, VL; Bellesso, M; Chamone, DA; Costa, RO; Hallack Neto, AE; Pereira, J; Ruiz, MA | 1 |
2 other study(ies) available for vidarabine and Aggressive Natural Killer Cell Leukemia
| Article | Year |
|---|---|
T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Leukemia, Large Granular Lymphocytic; Male; Middle Aged; Prednisone; Vidarabine; Vincristine | 2010 |
T-cell large granular lymphocytic leukemia: treatment experience with fludarabine.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Leukemia, Large Granular Lymphocytic; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Vidarabine; Young Adult | 2012 |